775 related articles for article (PubMed ID: 11402001)
1. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
Mulvey MA; Schilling JD; Hultgren SJ
Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001
[TBL] [Abstract][Full Text] [Related]
2. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
Mulvey MA; Schilling JD; Martinez JJ; Hultgren SJ
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8829-35. PubMed ID: 10922042
[TBL] [Abstract][Full Text] [Related]
3. A Murine Model for Escherichia coli Urinary Tract Infection.
Hannan TJ; Hunstad DA
Methods Mol Biol; 2016; 1333():159-75. PubMed ID: 26468108
[TBL] [Abstract][Full Text] [Related]
4. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
[TBL] [Abstract][Full Text] [Related]
5. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
Danka ES; Hunstad DA
J Infect Dis; 2015 Apr; 211(7):1164-73. PubMed ID: 25336727
[TBL] [Abstract][Full Text] [Related]
6. Dynamic interactions between host and pathogen during acute urinary tract infections.
Schilling JD; Mulvey MA; Hultgren SJ
Urology; 2001 Jun; 57(6 Suppl 1):56-61. PubMed ID: 11378051
[TBL] [Abstract][Full Text] [Related]
7. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
Mulvey MA; Lopez-Boado YS; Wilson CL; Roth R; Parks WC; Heuser J; Hultgren SJ
Science; 1998 Nov; 282(5393):1494-7. PubMed ID: 9822381
[TBL] [Abstract][Full Text] [Related]
8. Detection of intracellular bacterial communities in human urinary tract infection.
Rosen DA; Hooton TM; Stamm WE; Humphrey PA; Hultgren SJ
PLoS Med; 2007 Dec; 4(12):e329. PubMed ID: 18092884
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.
Smith MA; Weingarten RA; Russo LM; Ventura CL; O'Brien AD
Infect Immun; 2015 Apr; 83(4):1661-73. PubMed ID: 25667267
[TBL] [Abstract][Full Text] [Related]
10. Microbiology. Pods invade infected bladders.
Ferber D
Science; 2003 Jul; 301(5629):31. PubMed ID: 12843366
[No Abstract] [Full Text] [Related]
11. Intracellular bacterial biofilm-like pods in urinary tract infections.
Anderson GG; Palermo JJ; Schilling JD; Roth R; Heuser J; Hultgren SJ
Science; 2003 Jul; 301(5629):105-7. PubMed ID: 12843396
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
[TBL] [Abstract][Full Text] [Related]
13. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.
Steigedal M; Marstad A; Haug M; Damås JK; Strong RK; Roberts PL; Himpsl SD; Stapleton A; Hooton TM; Mobley HL; Hawn TR; Flo TH
J Immunol; 2014 Dec; 193(12):6081-9. PubMed ID: 25398327
[TBL] [Abstract][Full Text] [Related]
15. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.
Wright KJ; Seed PC; Hultgren SJ
Infect Immun; 2005 Nov; 73(11):7657-68. PubMed ID: 16239570
[TBL] [Abstract][Full Text] [Related]
16. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
[TBL] [Abstract][Full Text] [Related]
17. [Disturbance of the local vesicular defense as a cause of cystitis manifestation].
Krüger C; Grande R; Wöhrmann W; Commichau R
Zentralbl Bakteriol Orig A; 1974; 227(1-4):321-6. PubMed ID: 4154604
[No Abstract] [Full Text] [Related]
18. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
Eto DS; Jones TA; Sundsbak JL; Mulvey MA
PLoS Pathog; 2007 Jul; 3(7):e100. PubMed ID: 17630833
[TBL] [Abstract][Full Text] [Related]
19. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
Anderson GG; Dodson KW; Hooton TM; Hultgren SJ
Trends Microbiol; 2004 Sep; 12(9):424-30. PubMed ID: 15337164
[TBL] [Abstract][Full Text] [Related]
20. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.
Hannan TJ; Totsika M; Mansfield KJ; Moore KH; Schembri MA; Hultgren SJ
FEMS Microbiol Rev; 2012 May; 36(3):616-48. PubMed ID: 22404313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
